Do basophils release histamine and drive Th2 allergic inflammation, while Th2 signaling recruits eosinophils?

Clinical and immunological evidence

• Basophil-Driven Allergic Initiation: Basophils are critical innate effector cells that undergo rapid activation during type-2 immunological challenges. Upon crosslinking of high-affinity IgE receptors ($\text{Fc}\epsilon\text{RI}$) by allergen-IgE complexes, basophils rapidly degranulate, releasing substantial quantities of histamine. This release acts on $\text{H}_1$ and $\text{H}_4$ receptors to drive immediate physiological allergy manifestations, including vascular permeability, smooth muscle contraction, and tissue inflammation.
• Eosinophil Recruitment and Survival: Eosinophils are tightly regulated by type 2 helper T ($\text{Th2}$) signaling. The cytokines interleukin-4 ($\text{IL-4}$), $\text{IL-13}$, and $\text{IL-5}$ coordinate their development, egress, chemotaxis, and tissue localization. While $\text{IL-4}$ and $\text{IL-13}$ condition local tissue to upregulate vascular cell adhesion molecule-1 ($\text{VCAM-1}$) and the chemokine $\text{CCL11}$ (eotaxin-1), $\text{IL-5}$ stimulates eosinophilopoiesis and mobilizes mature cells from the bone marrow.

Mechanistic explanations

• Th2 Polarization Pathway: Activated basophils act as a principal early source of $\text{IL-4}$. This basophil-derived $\text{IL-4}$ binds to $\text{IL-4R}\alpha$ on dendritic cells and naïve $\text{CD4}^+$ T cells, triggering the $\text{JAK-STAT6}$ pathway to upregulate $\text{GATA3}$, the master transcription factor for $\text{Th2}$ cell differentiation.
• Intracellular Eosinophil Activation: Once recruited, eosinophils are activated and protected from apoptosis by $\text{IL-5}$ binding to its receptor ($\text{IL-5R}\alpha$ and the common $\beta\text{c}$ chain). This triggers $\text{JAK2-STAT5}$, $\text{PI3K/AKT}$, and $\text{Ras-Raf-ERK}$ ($\text{MAPK}$) signaling. Specifically, $\text{STAT5}$ activation upregulates survival genes, and $\text{NF}-\kappa\text{B}$ transcription drives the anti-apoptotic protein $\text{Bcl-xL}$ to prolong eosinophil lifespan, while $\text{PI3K}$ and $\text{MAPK}$ pathways drive motility and the degranulation of cytotoxic proteins like eosinophil cationic protein ($\text{ECP}$).

[Basophils] --(IgE crosslinking)--> Release Histamine & IL-4
                                          │
                                   (JAK-STAT6/GATA3)
                                          ▼
                                   [Th2 Polarization]
                                          │
                                 Releases IL-5, IL-4, IL-13
                                          │
                    ┌─────────────────────┴─────────────────────┐
                    ▼                                           ▼
      [Tissue Conditioning (IL-4/13)]               [Survival & Activation (IL-5)]
     (Upregulates VCAM-1 & CCL11)                      (JAK2-STAT5 & PI3K/MAPK)
                    │                                           │
                    └──────────────────► [Eosinophils] ◄────────┘
                                   (Recruited & Activated)

Bottom line

The physiological claim is fully supported. Basophils initiate the immediate allergic response by releasing histamine and drive chronic $\text{Th2}$ polarization via early $\text{IL-4}$ secretion, while the resulting $\text{Th2}$ cytokines ($\text{IL-4}$, $\text{IL-13}$, and $\text{IL-5}$) downstream coordinate the recruitment, tissue homing, activation, and survival of tissue-damaging eosinophils.